Itau Unibanco Holding S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

A detailed history of Itau Unibanco Holding S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 86 shares of REGN stock, worth $64,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86
Previous 40 115.0%
Holding current value
$64,760
Previous $42,000 114.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $47,108 - $55,280
46 Added 115.0%
86 $90,000
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $35,328 - $42,847
40 New
40 $42,000
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $75,967 - $86,406
-98 Reduced 40.5%
144 $126,000
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $12,464 - $15,198
18 Added 8.04%
242 $199,000
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $100,804 - $119,570
144 Added 180.0%
224 $160,000
Q1 2023

May 12, 2023
SELL
$680.49 - $826.97 $217,076 - $263,803
-319 Reduced 79.95%
80 $65,000
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $51,529 - $55,946
-73 Reduced 15.47%
399 $287,000
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $195,723 - $246,993
341 Added 260.31%
472 $325,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $190,277 - $256,377
-347 Reduced 72.59%
131 $77,000
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $214,838 - $252,133
361 Added 308.55%
478 $334,000
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $239,131 - $295,226
-440 Reduced 78.99%
117 $75,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $173,931 - $206,330
303 Added 119.29%
557 $337,000
Q2 2021

Aug 17, 2021
BUY
$472.8 - $558.54 $120,091 - $141,869
254 New
254 $142,000
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $21,271 - $29,452
-71 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $4,029 - $4,836
-12 Reduced 14.46%
71 $26,000
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $144,318 - $167,897
-411 Reduced 83.2%
83 $34,000
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $31,875 - $38,638
-112 Reduced 18.48%
494 $170,000
Q1 2018

May 14, 2018
BUY
$315.82 - $393.78 $180,649 - $225,242
572 Added 1682.35%
606 $209,000
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $717 - $939
2 Added 6.25%
34 $13,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $13,804 - $16,128
32
32 $45,000

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email